| 2025-08-12 | 10-Q | 10.1 | Inovio Pharmaceuticals, Inc. Amended and Restated 2023 Omnibus Incentive Plan (filed herewith). |
|---|
| 2024-03-06 | 10-K | 10.20 | Participation Agreement under Severance Plan for Michael Sumner (filed herewith). |
|---|
| 2024-03-06 | 10-K | 10.19 | Participation Agreement under Severance Plan for Laurent Humeau (filed herewith). |
|---|
| 2024-03-06 | 10-K | 10.18 | Participation Agreement under Severance Plan for Jacqueline Shea (filed herewith). |
|---|
| 2024-03-06 | 10-K | 10.17 | Inovio Pharmaceuticals, Inc. Severance Plan and Summary Plan Description (filed herewith). |
|---|
| 2024-03-06 | 10-K | 10.11 | First Amendment to the Amended and Restated License and Collaboration Agreement, dated June 14, 2023, by and between Inovio Pharmaceuticals, Inc. and Beijing Apollo Saturn Biological Technology Limited (filed herewith). |
|---|
| 2023-08-09 | 10-Q | 10.3 | Form of RSU Grant Package under 2023 Omnibus Incentive Plan (filed herewith). |
|---|
| 2023-08-09 | 10-Q | 10.2 | Form of Option Grant Package under 2023 Omnibus Incentive Plan (filed herewith). |
|---|
| 2023-05-18 | 8-K | 10.1 | Inovio Pharmaceuticals, Inc. 2023 Omnibus Incentive Plan |
|---|
| 2022-08-09 | 10-Q | 10.1 | Separation Agreement, dated as of May 10, 2022, by and between the registrant and J. Joseph Kim (filed herewith). |
|---|
| 2021-11-09 | 10-Q | 10.1 | ATM Equity OfferingSM Sales Agreement dated November 9, 2021 by and among Inovio Pharmaceuticals, Inc., BofA Securities, Inc., RBC Capital Markets, LLC and Oppenheimer & Co. Inc. |
|---|
| 2021-08-09 | 10-Q | 10.1 | Amended and Restated Collaboration and License Agreement dated June 7, 2021, by and between Inovio Pharmaceuticals, Inc. and Advaccine Biopharmaceuticals Suzhou Co., Ltd. (filed herewith). |
|---|
| 2021-03-01 | 10-K | 10.14 | Collaboration and License Agreement dated December 31, 2020 between Inovio Pharmaceuticals, Inc. and Advaccine Biopharmaceuticals Suzhou Co., Ltd. (filed herewith). |
|---|
| 2020-08-10 | 10-Q | 10.2 | Award Agreement dated June 18, 2020 between Inovio Pharmaceuticals, Inc. and Natick Contracting Division (filed herewith).# |
|---|
| 2020-08-10 | 10-Q | 10.1 | Other Transaction Authority For Prototype Agreement dated June 22, 2020 between Inovio Pharmaceuticals, Inc. and Natick Contracting Division (filed herewith).# |
|---|
| 2020-03-12 | 10-K | 10.27 | Employment Agreement dated as of March 4, 2019 between Inovio Pharmaceuticals, Inc. and Laurent M. Humeau (filed herewith). |
|---|
| 2020-03-12 | 10-K | 10.26 | Employment Agreement dated March 8, 2019 between Inovio Pharmaceuticals, Inc. and Jacqueline E. Shea (filed herewith). |
|---|
| 2020-01-02 | 8-K | 10.1 | Registration Rights Agreement, dated December 26, 2019, by and between the Company and the Purchaser. |
|---|
| 2019-05-10 | 8-K | 10.1 | Inovio Pharmaceuticals, Inc. 2016 Omnibus Incentive Plan, as amended. |
|---|
| 2019-05-09 | 10-Q | 10.1 | Separation Agreement dated March 26, 2019 by and between Inovio Pharmaceuticals, Inc. and Dr. Mark Bagarazzi (filed herewith). |
|---|
| 2019-03-12 | 10-K | 10.43 | Consulting Agreement dated February 21, 2019 by and between Inovio Pharmaceuticals, Inc. and Dr. Niranjan Sardesai (filed herewith). |
|---|
| 2018-03-14 | 10-K | 10.12 | Amended and Restated License and Collaboration Agreement, dated December 29, 2017, by and between Inovio Pharmaceuticals, Inc. and Beijing Apollo Saturn Biological Technology Limited (filed herewith). |
|---|
| 2017-08-08 | 10-Q | 10.2 | Sublease dated June 21, 2017 between Accolade, Inc. and Inovio Pharmaceuticals, Inc. (Filed herewith.) |
|---|
| 2017-08-08 | 10-Q | 10.1 | Second Amendment to the Lease Agreement dated June 22, 2017 between Brandywine Operating Partnership, L.P. and Inovio Pharmaceuticals, Inc. (Filed herewith.) |
|---|
| 2017-03-15 | 10-K | 10.56 | Form of Nonqualified Stock Option Agreement under 2016 Omnibus Incentive Plan. (Filed herewith.) |
|---|
| 2017-03-15 | 10-K | 10.55 | Form of Incentive Stock Option Agreement under 2016 Omnibus Incentive Plan. (Filed herewith.) |
|---|
| 2017-03-15 | 10-K | 10.54 | Form of Restricted Stock Units Award Agreement under 2016 Omnibus Incentive Plan. (Filed herewith.) |
|---|
| 2016-11-09 | 10-Q | 10.6 | Form of Restricted Stock Agreement under the GENEOS Therapeutics, Inc. 2016 Equity Incentive Plan (filed herewith). |
|---|
| 2016-11-09 | 10-Q | 10.5 | Form of Outside Director Non-Qualified Stock Option Agreement under the GENEOS Therapeutics, Inc. 2016 Equity Incentive Plan (filed herewith). |
|---|
| 2016-11-09 | 10-Q | 10.4 | Form of Employee Non-Qualified Stock Option Agreement under the GENEOS Therapeutics, Inc. 2016 Equity Incentive Plan (filed herewith). |
|---|
| 2016-11-09 | 10-Q | 10.3 | Form of Incentive Stock Option Agreement under the GENEOS Therapeutics, Inc. 2016 Equity Incentive Plan (filed herewith). |
|---|
| 2016-11-09 | 10-Q | 10.2 | GENEOS Therapeutics, Inc. 2016 Equity Incentive Plan (filed herewith). |
|---|
| 2016-11-09 | 10-Q | 10.1 | Office Lease Agreement dated October 10, 2016 by and between 6759 Mesa Ridge Road Holdings, LLC and Inovio Pharmaceuticals, Inc. (filed herewith). |
|---|
| 2016-05-09 | 10-Q | 10.2 | Collaborative Research Agreement dated March 14, 2016 by and between The Wistar Institute of Anatomy and Biology, a Commonwealth of Pennsylvania nonprofit corporation, and Inovio Pharmaceuticals, Inc. (filed herewith). |
|---|
| 2016-05-09 | 10-Q | 10.1 | Collaborative Research Agreement dated March 14, 2016 by and between The Wistar Institute of Anatomy and Biology, a Commonwealth of Pennsylvania nonprofit corporation, and Inovio Pharmaceuticals, Inc. (filed herewith). |
|---|
| 2016-03-14 | 10-K | 10.12 | Amended and Restated 2007 Omnibus Incentive Plan, as amended (filed herewith). |
|---|
| 2015-11-09 | 10-Q | 10.1 | DNA Cancer Vaccine Collaboration and License Agreement dated as of August 7, 2015 by and between MedImmune, Limited and Inovio Pharmaceuticals, Inc. (filed herewith) (Inovio has applied with the Secretary of the Securities and Exchange Commission for confidential treatment of certain confidential portions of this exhibit pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.). |
|---|
| 2015-03-16 | 10-K | 10.12 | Amended and Restated 2007 Omnibus Incentive Plan, as amended (filed herewith). |
|---|
| 2014-11-10 | 10-Q | 10.3 | Second Amendment to Employment Agreement dated November 7, 2014 by and between Inovio Pharmaceuticals, Inc. and Dr. Niranjan Sardesai (filed herewith). |
|---|
| 2014-11-10 | 10-Q | 10.2 | Second Amendment to Employment Agreement dated November 7, 2014 by and between Inovio Pharmaceuticals, Inc. and Peter Kies (filed herewith). |
|---|
| 2014-11-10 | 10-Q | 10.1 | Second Amendment to Employment Agreement dated November 7, 2014 by and between Inovio Pharmaceuticals, Inc. and Dr. Mark Bagarazzi (filed herewith). |
|---|
| 2014-03-17 | 10-K | 10.36 | LEASE AGREEMENT |
|---|
| 2013-11-12 | 10-Q | 10.2 | Termination of Voting Trust Agreement dated as of November 8, 2013 (filed herewith). |
|---|
| 2013-09-12 | 8-K | 10.1 | Collaboration, Option and License Agreement dated as of September 9, 2013 between F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. and Inovio Pharmaceuticals, Inc. (Inovio has applied with the Secretary of the Securities and Exchange Commission for confidential treatment of certain confidential portions of this exhibit pursuant to Rule 24b-2 of the Securities Exchange Act of 1934.) |
|---|
| 2013-05-10 | 10-Q | 10.1 | Lease Agreement dated April 9, 2013 by and between BMR-Wateridge, LP and Inovio Pharmaceuticals, Inc. (filed herewith). |
|---|
| 2013-03-18 | 10-K | 10.44 | AMENDMENT TO EMPLOYMENT AGREEMENT |
|---|
| 2013-03-18 | 10-K | 10.43 | AMENDMENT TO EMPLOYMENT AGREEMENT |
|---|
| 2013-03-18 | 10-K | 10.42 | AMENDMENT TO EMPLOYMENT AGREEMENT |
|---|
| 2013-03-18 | 10-K | 10.41 | AMENDMENT TO EMPLOYMENT AGREEMENT |
|---|
| 2013-03-18 | 10-K | 10.12 | AMENDED AND RESTATED 2007 OMNIBUS INCENTIVE PLAN |
|---|
| 2012-03-15 | 10-K | 10.39 | EMPLOYMENT AGREEMENT |
|---|
| 2012-03-15 | 10-K | 10.7 | EMPLOYMENT AGREEMENT |
|---|
| 2011-11-07 | 10-Q | 10.1 | COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT |
|---|
| 2011-03-16 | 10-K | 10.5 | EMPLOYMENT AGREEMENT |
|---|
| 2011-01-24 | 8-K | 10.1 | Form of Investor Purchase Agreement |
|---|
| 2010-05-17 | 10-Q | 10.2 | LICENSE AND COLLABORATION AGREEMENT |
|---|
| 2010-05-17 | 10-Q | 10.1 | AMENDED AND RESTATED 2007 OMNIBUS INCENTIVE PLAN |
|---|
| 2010-03-26 | 10-K | 10.1 | Lease Agreement by and between the registrant and 1787 Sentry Park West LLC dated December 10, 2009. |
|---|
| 2009-11-13 | 10-Q | 10.2 | Amended and Restated 2007 Omnibus Incentive Plan |
|---|
| 2009-10-06 | 8-K | 10.1 | Amended and Restated Employment Agreement dated October 6, 2009 by and between Inovio Biomedical Corporation and Dr. Avtar Dhillon |
|---|
| 2009-08-19 | 10-Q | 10.1 | Form of Indemnification Agreement for Directors and Officers of Inovio Biomedical Corporation. |
|---|
| 2009-07-30 | 8-K | 10.2 | Form of Securities Purchase Agreement |
|---|
| 2009-07-30 | 8-K | 10.1 | Placement Agency Agreement dated July 29, 2009 by and between the Company and Rodman & Renshaw, LLP |
|---|
| 2009-06-02 | 8-K | 10.2 | Amended and Restated 2000 Stock Option Plan. |
|---|
| 2009-06-02 | 8-K | 10.1 | Voting Trust Agreement dated June 1, 2009. |
|---|